CareDx to Participate in Upcoming Investor Conference
BRISBANE, Calif., Sept. 21, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (NASDAQ: CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients, today announced that Peter Maag, Chief Executive Officer, and Michael Bell, Chief Financial Officer, will be participating in the Cantor Fitzgerald Global Healthcare Conference, to be held October 1-3, 2018 in New York, NY. The company is scheduled to present on Tuesday, October 2, 2018 at 3:25 PM ET.
A live audio webcast of the Cantor Fitzgerald Global Healthcare Conference presentation will be available online from the investor relations section of the CareDx website at https://investors.caredxinc.com/. The webcast replay of the presentation will be available approximately one hour following the conclusion of the live presentation and will be available on the Company’s website for 90 days.
About CareDx CareDx, Inc., headquartered in Brisbane, California, is a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for transplant recipients. CareDx offers products along the pre- and post-transplant testing continuum.
For more information, please visit: www.CareDx.com.
Investor RelationsDavid ClairIntegrated Corporate Relations, Inc.firstname.lastname@example.org